Sean McCutcheon
Stock Analyst at Raymond James
(4.50)
# 1,101
Out of 4,707 analysts
44
Total ratings
43.8%
Success rate
40.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $24 → $22 | $8.86 | +148.31% | 2 | Sep 9, 2026 | |
| XNCR Xencor | Rated: Buy | $40 → $46 | $25.33 | +81.60% | 2 | Sep 1, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $76 → $248 | $207.32 | +19.62% | 3 | Aug 27, 2026 | |
| BDTX Black Diamond Therapeutics | Maintained: Buy | $11 | $2.10 | +423.81% | 3 | Aug 6, 2026 | |
| FTH Faeth Therapeutics | Initiated Coverage: Buy | $56 | $39.20 | +42.86% | 1 | Jul 31, 2026 | |
| RLAY Relay Therapeutics | Maintained: Buy | $19 → $26 | $19.11 | +36.05% | 2 | May 19, 2026 | |
| ENGN enGene Therapeutics | Maintained: Buy | $27 → $4 | $1.92 | +108.33% | 5 | May 8, 2026 | |
| CMPX Compass Therapeutics | Downgraded: Hold | n/a | $2.21 | - | 3 | Apr 28, 2026 | |
| VIR Vir Biotechnology | Maintained: Buy | $12 → $19 | $11.18 | +69.95% | 4 | Feb 24, 2026 | |
| RGNX REGENXBIO | Reiterated: Buy | $29 | $8.76 | n/a | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.63 | n/a | 4 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $64.69 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $810.31 | n/a | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $65 | $20.04 | n/a | 1 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 | $20.49 | n/a | 3 | Jun 13, 2025 |
BridgeBio Oncology Therapeutics
Sep 9, 2026
Maintained: Buy
Price Target: $24 → $22
Current: $8.86
Upside: +148.31%
Xencor
Sep 1, 2026
Rated: Buy
Price Target: $40 → $46
Current: $25.33
Upside: +81.60%
Revolution Medicines
Aug 27, 2026
Maintained: Buy
Price Target: $76 → $248
Current: $207.32
Upside: +19.62%
Black Diamond Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $11
Current: $2.10
Upside: +423.81%
Faeth Therapeutics
Jul 31, 2026
Initiated Coverage: Buy
Price Target: $56
Current: $39.20
Upside: +42.86%
Relay Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $19 → $26
Current: $19.11
Upside: +36.05%
enGene Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $27 → $4
Current: $1.92
Upside: +108.33%
Compass Therapeutics
Apr 28, 2026
Downgraded: Hold
Price Target: n/a
Current: $2.21
Upside: -
Vir Biotechnology
Feb 24, 2026
Maintained: Buy
Price Target: $12 → $19
Current: $11.18
Upside: +69.95%
REGENXBIO
Sep 5, 2025
Reiterated: Buy
Price Target: $29
Current: $8.76
Upside: n/a
Jul 24, 2025
Reiterated: Hold
Price Target: n/a
Current: $27.63
Upside: n/a
Jul 17, 2025
Maintained: Hold
Price Target: n/a
Current: $64.69
Upside: n/a
Jul 17, 2025
Maintained: Hold
Price Target: n/a
Current: $810.31
Upside: n/a
Jul 11, 2025
Initiated Coverage: Buy
Price Target: $65
Current: $20.04
Upside: n/a
Jun 13, 2025
Maintained: Buy
Price Target: $86
Current: $20.49
Upside: n/a